Precursor Condition
High Grade Cervical Intraepithelial Neoplasia
CI-CAN-00002873Explore in graph →
Precursor14 active trials
- NCIt
- C7670
Loading cancer entity…
Precursor Condition
CI-CAN-00002873Explore in graph →
Clinical trials
50 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07454915 | PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical Dysplasia | recruiting | Phase 2 | 138 | PapiVax Biotech, Inc.OTHER | 2 | May 6, 2026 | clinicaltrials |
| NCT04712851 | Pembrolizumab for the Treatment of Cervical Intraepithelial Neoplasia | recruiting | Phase 2 | 25 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Mar 10, 2026 | clinicaltrials |
| NCT04098744 |
| Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)(ART-CIN_IIB) |
| recruiting |
| Phase 2 |
| 78 |
| Frantz Viral Therapeutics, LLCINDUSTRY |
| 1 |
| Oct 2, 2025 |
| clinicaltrials |
Data updated 22 days agoSource updated May 6, 2026source: clinicaltrials